Search Results 1261-1270 of 17094 for monoclonal antibody

1. Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

   Patients who have received any continuous or intermittent small molecule therapeutics (excluding monoclonal antibodies) ≤ 5 effective half-lives prior to ...

2. Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer - Mayo Clinic

   Monoclonal antibodies =< 2 weeks; Radiation therapy =< 2 weeks; Anti-Her-2 or other "targeted" (e.g. mammalian target of rapamycin [mTOR]) therapy =< 2 weeks.

3. A Study of Taxane, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Metastatic Breast Cancer Patients - Mayo Clinic

   ... antibody (HBcAb) test at screening, are eligible for the study if active HBV infection is ruled out on the basis of HBV deoxyribonucleic acid (DNA) viral ...

4. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

   Patients who have received any continuous or intermittent small molecule therapeutics (excluding monoclonal antibodies) ≤ 5 effective half-lives prior to ...

5. Immunometabolism and Cancer Immunology Laboratory - Mayo Clinic Research

   Immunotherapies that instruct the immune system to specifically target tumors have recently been discovered. Development of effective blocking antibodies ...

6. A Study Evaluating the Safety and Effectiveness of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) for Adults Hospitalized with Influenza - Mayo Clinic

   The purpose of this study is to test the safety and effectiveness of an antibody ... monoclonal gammopathy); Presence of any pre-existing illness that, in ...

7. Study of Cabozantinib Combined With Atezolizumab Vs. Second Novel Hormonal Therapy in Subjects with Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

   formulations or history of severe infusion-related reactions to monoclonal antibodies - Any other active malignancy at time of randomization or diagnosis of ...

8. Mayo Clinic News Network Title: Immunotherapy for Alzheimer’s Disease / Date: January 2017 Intro: Alzheimer’s d

   The antibodies target unwanted excess proteins, ideally before they can kill nerve cells in the brain, explains researcher and behavioral neurologist David ...

9. Focus Areas - Division of Nephrology and Hypertension - Mayo Clinic Research

   Monoclonal gammopathy. Nelson Leung, M.D., studies kidney diseases caused by monoclonal ... Schinstock studies therapy for chronic antibody-mediated rejection ...

10. An Open-label Study to Investigate the Efficacy, Safety and Tolerability of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy - Mayo Clinic

    The subject has a history of immunoglobulin M (IgM) paraproteinemia, including IgM monoclonal gammopathy with high titer of antibody to myelin-associated ...